1. Home
  2. BGNE vs RCI Comparison

BGNE vs RCI Comparison

Compare BGNE & RCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGNE
  • RCI
  • Stock Information
  • Founded
  • BGNE 2010
  • RCI 1960
  • Country
  • BGNE Cayman Islands
  • RCI Canada
  • Employees
  • BGNE N/A
  • RCI N/A
  • Industry
  • BGNE Biotechnology: Pharmaceutical Preparations
  • RCI Cable & Other Pay Television Services
  • Sector
  • BGNE Health Care
  • RCI Telecommunications
  • Exchange
  • BGNE Nasdaq
  • RCI Nasdaq
  • Market Cap
  • BGNE 19.2B
  • RCI 21.6B
  • IPO Year
  • BGNE 2016
  • RCI N/A
  • Fundamental
  • Price
  • BGNE $175.87
  • RCI $30.75
  • Analyst Decision
  • BGNE Buy
  • RCI Buy
  • Analyst Count
  • BGNE 8
  • RCI 4
  • Target Price
  • BGNE $253.69
  • RCI $61.75
  • AVG Volume (30 Days)
  • BGNE 476.1K
  • RCI 1.3M
  • Earning Date
  • BGNE 11-12-2024
  • RCI 01-30-2025
  • Dividend Yield
  • BGNE N/A
  • RCI 4.65%
  • EPS Growth
  • BGNE N/A
  • RCI 42.33
  • EPS
  • BGNE N/A
  • RCI 2.09
  • Revenue
  • BGNE $3,351,304,621.00
  • RCI $15,143,417,589.00
  • Revenue This Year
  • BGNE $969.39
  • RCI $9.60
  • Revenue Next Year
  • BGNE $24.79
  • RCI $2.87
  • P/E Ratio
  • BGNE N/A
  • RCI $14.70
  • Revenue Growth
  • BGNE 50.22
  • RCI 12.78
  • 52 Week Low
  • BGNE $126.97
  • RCI $30.73
  • 52 Week High
  • BGNE $248.16
  • RCI $48.19
  • Technical
  • Relative Strength Index (RSI)
  • BGNE 34.52
  • RCI 14.69
  • Support Level
  • BGNE $174.50
  • RCI $35.53
  • Resistance Level
  • BGNE $180.00
  • RCI $36.28
  • Average True Range (ATR)
  • BGNE 6.73
  • RCI 0.69
  • MACD
  • BGNE -2.17
  • RCI -0.39
  • Stochastic Oscillator
  • BGNE 3.24
  • RCI 0.27

About BGNE BeiGene Ltd.

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2023, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 50% of BeiGene's revenue.

About RCI Rogers Communication Inc.

Rogers Communications is the largest wireless service provider in Canada, with its more than 11 million subscribers equating to one third of the total Canadian market. Its wireless business accounted for more than half of total revenue and has increasingly been providing a bigger portion of total company sales over the last several years. Rogers' cable segment, which provides about 35% of total revenue after acquiring Shaw, offers home internet, television, and landline phone service to consumers and businesses. Remaining sales come from Rogers' media unit, which owns and operates various television and radio stations and the Toronto Blue Jays. Rogers' significant exposure to sports also includes ownership stakes in the Toronto Maple Leafs, Raptors, FC, and Argonauts.

Share on Social Networks: